KENDIE TILDEN: Open Payments
NPI 1871371484 · SIERRA VISTA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 24 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $354 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Astellas Pharma US Inc | 3 | $61 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Amgen Inc. | 3 | $49 |
| PFIZER INC. | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| SANOFI PASTEUR INC. | 1 | $21 |
| Novo Nordisk Inc | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: Veozah, TRELEGY ELLIPTA, AIRSUPRA, EVENITY, Belbuca, GVOKE HYPOPEN, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, Rybelsus.
Industry payments across AZ — which companies pay providers there.
